ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Di Martino, E, Alder, O orcid.org/0000-0002-7975-9727, Hurst, CD orcid.org/0000-0001-7719-1325 et al. (1 more author) (2019) ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer. Scientific Reports, 9. ARTN: 5740. ISSN 2045-2322

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Dates:
  • Published: 5 April 2019
  • Accepted: 14 November 2018
  • Published (online): 5 April 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Oncology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Section of Experimental Oncology (Leeds)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchL372
Depositing User: Symplectic Publications
Date Deposited: 15 Nov 2018 13:58
Last Modified: 07 May 2019 15:01
Status: Published
Publisher: Nature Publishing Group
Identification Number: https://doi.org/10.1038/s41598-018-36456-3

Share / Export

Statistics